We tested the possibility of using LH and thyroxine (T 4 ) to restore the testicular steroidogenic ability in aged Brown Norway rats. Three-, 6-, 12-(n ‫؍‬ 8 per group), and 18-mo-old (n ‫؍‬ 32; 3M, 6M, 12M, and 18M, respectively) rats were used. The 18M rats were divided into four groups (n ‫؍‬ 8 per group) and implanted subdermally with Alzet mini-osmotic pumps containing saline (control), LH (24 g/day), T 4 (5 g/day), and LH؉T 4 (24؉5 g/day), respectively, for 4 wk (to 19 mo [19M] of age). Testis volume and absolute volumes of many testicular components were unchanged with advancing age and treatments, except for the blood vessels (occasional thickening), lymphatic space (increased), and Leydig cells (decreased with age but increased to the 3M level with LH and to the 12M level with both T 4 and LH؉T 4 , respectively). The number of Leydig and connective tissue cells per testis was unchanged with aging and treatments. The number of macrophages was significantly higher in treated rats. The average volume of a Leydig cell was significantly decreased in 12M and 19M control rats. However, LH and LH؉T 4 restored it to the 3M level, and T 4 restored to the 12M level. The steroidogenic ability of Leydig cells in vitro decreased when aging from the 3M to the 19M level, LH and T 4 enhanced it to the 12M level, and LH؉T 4 raised it to the 3M level. Serum LH was unchanged from 3M to 12M rats, significantly reduced in 19M control rats, and raised above the 3M values with both LH and LH؉T 4 treatment and above the 19M (control) values with T 4 treatment; the latter values were lower than the 3M level. Serum T 4 and tri-iodothyronine (T 3 ) were highest in 3M and 6M rats and declined in 12M and 19M control rats; the latter group had the lowest levels. In all treated groups, T 4 and T 3 levels were significantly above those of 19M control rats but were lower than those of 3M through 12M rats. Serum testosterone was unchanged from 3M to 12M rats but was reduced in 19M control rats. Both LH and T 4 significantly raised these values above the 19M control levels, but they were still lower than the 3M through 12M levels. Additionally, LH؉T 4 significantly raised the serum testosterone levels to those of 12M rats, but these values were significantly lower than those of 3M and 6M rats. These findings show that with 24؉5-g dose of LH؉T 4 per day for 4 wk, a 100% recovery of the average volume of a Leydig cell and its steroidogenic ability in vitro and a 73% and 300% restoration of serum testosterone levels compared to 3M and 19M control rats, respectively, could be achieved in aged Brown Norway rats. A 100% reversibility 1
INTRODUCTION
The most obvious effect of aging on male reproduction is the progressive decrease in sexual activity from adolescence into old age [1] due to reduced circulating testosterone levels, which occur in all mammalian species studied to date, including humans [2] [3] [4] and rats [5] [6] [7] [8] . Testosterone is necessary in the male reproductive system for many functions, including the regulation of spermatogenesis in the testis, maintenance of the accessory sex organs, and the erectile function [9, 10] . Testosterone is also required in other organ systems of the mammalian male for their proper functioning. These include, but are not limited to, the brain (for libido and mood), skin (for hair growth and sebaceous gland activity), muscle (to increase muscle strength and volume), liver (to synthesize serum proteins), synovial tissue (to modulate immune responses), bone (to maintain strength and volume), bone marrow (to stimulate stem cells), and kidney (to stimulate erythropoietin) [9] [10] [11] [12] . Therefore, sustaining the normal levels of circulating testosterone clearly is important for the well-being of the male. Testosterone is primarily produced by the Leydig cells of the testis. Many studies regarding the effects of aging on Leydig cell structure and function have revealed that Leydig cells undergo atrophic changes in size [7, 8] and organelle content [13, 14] with aging, thus enabling them to go into a malfunctioning status.
Luteinizing hormone regulates the Leydig cell structure and function. Leydig cell size (i.e., average volume) is generally dependent on LH [15, 16] , and the testosterone-secretory capacity of Leydig cells has a positive correlation with their size [15] [16] [17] . Thyroid hormones are important in cellular differentiation [18] . More importantly, thyroid hormones are critical in the process of differentiation of precursor cells to Leydig cells in the postnatal rat testis [19] [20] [21] . The specific effects of thyroid hormone on mature Leydig cells are not clear at present. It is reported that reduced numbers of identifiable Leydig cells, together with increased numbers of connective tissue/mesenchymal cells, are observed in the testis interstitium of rats subjected to hypothyroidism [22] . If the differentiation of connective tissue/mesenchymal cells into Leydig cells requires thyroid hormone [18] [19] [20] , the levels of which are reduced with aging [23, 24] , then it is possible to hypothesize that the reduced steroidogenic potential of the aged Leydig cells could be due to the dedifferentiation of many Leydig cells toward their connective tissue precursor cells under the reduced thyroid hormone levels that occur with aging.
Circulating levels of LH are reduced in many strains of rats [6, 8, [25] [26] [27] , including the Brown Norway strain [27] , except for the report by Chen et al. [7] . Although statistically not significant, the results of their study [7] clearly showed that the mean value for serum LH in older rats was 33% lower than in young rats. In addition, thyroid hormones are reduced with aging [23, 24] . These hormonal changes can be explained, at least in part, by direct (LH secretion) and indirect (thyrotrophin/thyroid-stimulating hormone [TSH] action on the thyroid gland) effects that occur as a result of the pituitary aging. Based on this information, we hypothesize that these atrophic and dedifferentiated Leydig cells in aged testes are caused, at least in part, by the defects generated as a result of the aged pituitary gland on LH and thyroid hormone levels in aged males. Therefore, one objective of the present study was to test the possibility of reversing these changes in aged Leydig cells by exogenous supplementation of thyroid hormone and/or LH to increase their testosterone-producing capacity to a level similar to that of the young. Rats have been suggested as suitable models for human aging studies [28] . The Brown Norway rat was chosen for this study, because this strain has been recommended as a suitable model for male reproductive aging studies [27, 29] .
According to previous reports [27, 29] , Brown Norway rats age differently than other strains of rats that have been studied to date [8, 13] . The second objective of the present study was to examine age-related changes in the interstitial components of the testis in Brown Norway rats, because to our knowledge, no such information (except for the changes in Leydig cells) is available in this strain.
MATERIALS AND METHODS

Animals and Treatments
Male Brown Norway rats aged 3, 6, 12 (n ϭ 8 per group), and 18 mo (n ϭ 32; 3M, 6M, 12M, and 18M, respectively) were purchased from Harlan (Madison, WI). The 18M rats were divided equally into four groups (n ϭ 8 per group). Under deep inhalation anesthesia (Metofane; Malincroft Veterinary, Inc., Mundelein, IL), these four groups of 18M rats were implanted subdermally with Alzet mini-osmotic pumps (model 2ML4; Alza Corporation, Palo Alto, CA) containing saline (control), LH (24 g/day; National Hormone and Pituitary Program, Los Angeles, CA), thyroxine (T 4 ; 5 g/day; Sigma, St. Louis, MO), and LH and T 4 (LHϩT 4 ; two pumps, 24 g/day of LH and 5 g/day of T 4 ), respectively, for 4 wk (to 19 mo [19M] of age). These doses of LH [16] and thyroid hormone [19] were used based on previously published studies. Rats were maintained under conditions of controlled temperature (25ЊC) and lighting (14L:10D) and were housed individually (one rat per cage). The animals were fed with Agway Prolab rat formula (Syracuse, NY) and water ad libitum until they were killed. The animal protocol used (no. 488) meets the guidelines of the National Institutes of Health and was approved by the University of Tennessee Animal Care and Concerns Committee.
Administration of Saline and Hormones
Pumps were filled with either saline, LH, or T 4 and were primed in saline for 3 h before implantation so that they would deliver their contents immediately on subdermal implantation into the interscapular region. The LHϩT 4 rats received two pumps each, one containing LH and one containing T 4 ; the other rats received one pump containing either saline, LH, or T 4 . After 4 wk of treatment, rats were killed and used as described below. In addition, implanted pumps were removed and examined to verify that they had delivered the contents as expected.
Serum Collection
Immediately after a rat was killed, blood was drawn from its heart using the cardiac puncture technique, serum prepared [8] , and stored at Ϫ20ЊC until assay.
RIA for Serum LH, T 4 , Tri-Iodothyronine, and Testosterone Serum LH hormone was quantified using a commercially available rLH (rat luteinizing hormone) kit (Amersham Pharmacia Biotech, Piscataway, NJ). The sensitivity of LH assay was 0.8 ng/ml. The interassay coefficient of variation was less than 10.97%, and the intraassay coefficient of variation was less than 6.5%. The cross-reactivity of the antibody for LH was 0.66% for rat TSH, 0.1% for rat growth hormone, less than 0.016% for rat FSH, less than 0.8% for rat prolactin, and less than 0.00092% for rat ACTH. Serum T 4 , tri-iodothyronine (T 3 ), and testosterone were assayed using commercially available kits (Coat-A-Count; DPC, Los Angeles, CA). The interassay coefficients of variation for T 4 , T 3 , and testosterone assays were less than 14.5%, 10%, and 11%, respectively. The intraassay coefficients of variation for T 4 , T 3 , and testosterone assays were less than 3.8%, 8.9%, and 9%, respectively. The antibody used in the T 4 assay had 2% cross-reactivity with T 3 , and the antibody used in the T 3 assay had less than 1% cross-reactivity with T 4 . The cross-reactivity of the antibody used in the testosterone RIA kit was 2.8% for dihydrotestosterone, 0.5% for androstenedione, and less than 0.02% for other steroids.
LH-Stimulated Testicular Steroidogenesis In Vitro
One testis of each rat in the 3M, 6M, 12M, and 19M age groups was removed, cleaned of fat, and weighed on a Mettler H54 balance to obtain the fresh testis weight. Using the flotation technique [17, 30, 31] , the specific gravity of the fresh testis was determined as described previously [30, 31] , and the fresh testis volume was calculated by dividing the fresh testis weight by the specific gravity (in metric units, specific gravity equals density). This measurement is required to express Leydig cell numbers per testis, because numerical density is obtained as a number per unit volume of the testis. The testis was then decapsulated, and the entire testis was incubated for 3 h in the same medium as described previously [19, 20, [32] [33] [34] to determine the LH-stimulated testosterone-secretory capacity per testis in vitro. Testosterone levels in the incubation medium were measured by RIA using commercially available kits (Coat-A-Count), and the details of the assay are given above (see RIA for Serum LH, T 4 , Tri-Iodothyronine, and Testosterone). Testosterone-secretory capacity per Leydig cell was calculated by dividing the testosterone-secretory capacity per testis by the number of Leydig cells per testis.
Fixation and Processing of Testis Tissue
The other testis of each rat in the 3M, 6M, 12M, and 19M age groups (n ϭ 8 per group) was fixed by whole-body perfusion [17, 20, 33, 34] , and the fixed testis was then weighed, the specific gravity measured, and the fixed testis volume calculated. These fixed testes were processed for microscopy and stereology as described previously [17, 20, 33, 34] . Shrinkage of testis tissue from the fresh to the processed state was determined as previously published [31] for use in the stereological studies. (We have measured right and left testis weights in several Brown Norway rats in a separate study and verified that they are similar in weight when they do not show any obvious differences in sizes.)
Microscopy and Stereology
Two tissue sections of 1 m in thickness and four sections apart were cut from the testis tissue blocks prepared for stereology using a LKB IV ultramicrotome and glass knives. These sections were stained with methylene blue. The volume density of testicular components, which is defined as the volume of the component per unit volume of testis tissue, was obtained via point counting as described previously [17, 20, 34] . Four corners of every tissue section (four fields/section, one section/block, and 10 blocks/rat, for a total of 40 fields/rat) were analyzed with an Olympus BH-2 light microscope. The unbiased sampling rule of Sterio [35] was used to avoid bias and overlapping of the fields tested. The tested components included seminiferous tubules, testis interstitium, lymphatic space, Leydig cells (identified by their distinct peripheral rim of nuclear heterochromatin and abundant granular cytoplasm), blood vessels, macrophages (identified by nuclear heterochromatin and vacuolated cytoplasm, which stains differently from Leydig cells), and connective tissue cells (peritubular myoid cells, fibroblasts, endothelial cells of blood and lymph vessels, and pericytes; these cells were identified by their location and elongated, spindle-like shape). The formula used to obtain the volume density of each testicular component was as follows: volume density of component ϭ (number of points on each component/total number of points on testis tissue) ϫ 100.
The numerical density of Leydig cells (number of cells per unit volume of testis) was obtained via the disector method [35] as described in detail previously [34] . The average volume of a Leydig cell was obtained by dividing the volume density of Leydig cells by the numerical density as published previously [17, 20, 31] . The number of Leydig cells per testis was calculated by multiplying the numerical density by the fresh testis volume [17, 20, 34, 35 ]. An Olympus BH-2 light microscope was used for photography.
Statistical Analysis
The PC SAS software was used to analyze the data. Results are expressed as mean Ϯ SEM. Significant differences (P Ͻ 0.05) between the means were determined by the Duncan multiple-range test after analysis of variance [36] .
RESULTS
The testis volumes and volume densities of testicular components are shown in Table 1 . The absolute volumes of testicular components per testis are given in Table 2 . The numbers of Leydig cells, macrophages, and connective tissue cells per testis and the average volume of a Leydig cell are shown in Table 3 . This information (except for the parameters of Leydig cells) is provided for comparison with other studies and will not be discussed further.
The absolute volume of Leydig cells per testis did not change with age advancement from 3M to 6M but was significantly reduced at 12M; a further reduction was seen at 19M (control). By contrast, all other 19M groups (i.e., LH-, T 4 -, and LHϩT 4 -treated) had higher values compared to 19M control rats; however, statistical significance was not observed between 19M T 4 -treated and 19M control rats due to the higher SEM in the latter group. Additionally, the value of the 19M LH-treated group was not significantly different from those of the 3M and 6M groups, and the values of the 19M T 4 -and 19M LHϩT 4 -treated groups were not significantly different from those of 12M rats.
The number of Leydig cells per testis (Table 3) was not significantly different among all experimental groups. The average volume of a Leydig cell (Table 3) was unchanged with age advancement from 3M to 6M; however, significant reductions were observed first in 12M rats and then in 19M control rats. The average volume of a Leydig cell in 19M LH-and LHϩT 4 -treated rats was not significantly different from those in 3M and 6M rats. This value in 19M T 4 -treated rats was significantly lower than those in 3M and 6M rats, although it was not significantly different from those in 19M LH-treated and 12M rats. Microscopic studies also revealed that the size of Leydig cell profiles in tissue sections progressively decreased with age (from 3M to 19M), and that these profiles in 19M LH-, T 4 -, and LHϩT 4 -treated rats appeared to be much larger than those in 19M control rats (Fig. 1) . Thickening of the walls of some blood vessels, mainly due to the accumulation of connective tissue cells, was also observed occasionally in 6M and older rats (Fig. 1) ; however, the amount of collagen in the testis interstitium, which usually increases with age advancement in other strains of rats, was not evident in this strain. Table 4 shows LH-stimulated testosterone-secretory capacity per testis and per Leydig cell in vitro. No difference was observed between 3M and 6M rats for both these parameters, but significant reductions were observed in 12M and 19M control rats. Both these parameters in 19M LHϩT 4 -treated rats were similar to those in 3M and 6M rats, and these values in 19M LH-and T 4 -treated rats were comparable to those in 12M rats.
Serum LH, T 4 , T 3 , and testosterone levels are shown in Table 5 . Serum LH levels were unchanged from 3M to 12M rats but were reduced significantly in 19M control and T 4 -treated rats compared with 3M through 12M rats. In 19M LH-and LHϩT 4 -treated rats, LH levels were greater than those of 3M to 12M rats. Both T 4 and T 3 levels in serum were highest in 3M and 6M rats and lowest in 19M control rats. These hormone levels in 19M T 4 -and LHϩT 4 -treated rats were similar to those in 12M rats and were higher than those in 19M LH-treated rats. Serum testosterone levels did not change significantly from 3M to 12M rats, although the mean value in 12M rats was approximately 20% lower than those in 3M and 6M rats. The lowest value was observed in 19M control rats; the values in 19M LH-, T 4 -, and LHϩT 4 -treated rats were significantly greater than 19M controls. Serum testosterone levels in 19M LH-and T 4 -treated rats were significantly lower than those in 3M through 12M rats. Although the serum testosterone levels in 19M LHϩT 4 -treated rats were not significantly different from those in 12M rats, they were 27% lower (P Ͻ 0.05) than those in 3M and 6M rats.
DISCUSSION
The present investigation showed no change in the mean testis volume (approximating testis weight in metric units) in Brown Norway rats with aging, which compares favorably with previously published results of studies using this strain [7, 29] . This is in contrast to observations in the Sprague-Dawley [8] and Wistar strains [13] , which show increased testis volumes and weights with aging. In the present study, we did not see significant differences in testis weights and volumes between the right and left testicles in 19M Brown Norway rats, although the occurrence of small and large testes has been reported previously in 21-mo [7] as well as in 22-and 30-mo [27] Brown Norway rats. One possible explanation for these differences could be the differences in the ages of these rats (i.e., 19 vs. 21, 22, and 30 mo).
To our knowledge, no other study reporting on changes in the testicular components of the aged testis and/or testis interstitium (excluding Leydig cells) in Brown Norway rats is available with which to compare the present findings, although such information is available for Sprague-Dawley [8] and Wistar rats [13] . Comparing these changes in Brown Norway rats with those in Sprague-Dawley and Wistar rats reveals both differences and similarities among these strains. In brief, Leydig cell hypotrophy and reduced steroidogenic capacity is also observed with aging in Sprague-Dawley [8] and Wistar rats [13] ; however, unlike in the Brown Norway rat, the number of Leydig cells per testis is increased with aging in Sprague-Dawley [8] and Wistar rats [13] . Occurrence of Leydig cell hyperplasia in the aged testes has also been reported in stallions [37] and humans [38] , and this suggests the existence of differences among species in addition to differences among strains within the same species for this parameter with aging. Increased collagen deposition and thickening of the blood vessels in the testis interstitium are described in aged Sprague-Dawley and Wistar rats [8, 13] . By contrast, the present study showed that these changes were either minimal or absent in aged Brown Norway rats. Occlusion of blood vessels is observed in human testis with aging [39] and other conditions associated with infertility [40] [41] [42] . These findings suggest that testicular aging occurs at a slower pace in Brown Norway rats compared with all other strains of rats studied so far.
The most important findings of the present study are the results of the treatments of aged Brown Norway rats with LH, T 4 , and LHϩT 4 regarding enhancement of the testicular steroidogenic function. It is interesting to note that these treatments did not cause specific changes in testis volume, absolute volumes of testicular components (except for the Leydig cells), and numbers of testicular interstitial cells (including the Leydig cells). However, all three treatments were able to increase the absolute volume of Leydig cells per testis and the average volume of a Leydig cell above that of aged, 19M control rats, which had the lowest values for these parameters when compared with all the treatment groups. We were intrigued to learn that separate treatment with LH or T 4 could improve the testicular steroidogenic potential in vitro to that of 12M rats, and that the combined treatment (LHϩT 4 ) was effective in upgrading this potential to those of 3M and 6M rats. These findings suggest that changes in the circulating levels of LH and T 4 are the major factors responsible for Leydig cell hypotrophy and loss in their steroidogenic potential with aging, although we do not rule out any direct and/or indirect effects of other hormones and factors on Leydig cells that could be associated with these age-related changes. It needs to be mentioned that, although the LHϩT 4 treatment upgraded the steroidogenic potential of Leydig cells in vitro to those of 3M and 6M rats, the serum testosterone levels of these rats were raised only to the level of 12M rats (i.e., 73% recovery compared to 3M rats). However, this enhancement is more than 300% compared to 19M control rats. We believe that this recovery is remarkable and warrants further research to achieve 100% recovery compared to 3M rats. Among the possibilities for the lower serum testosterone levels in LHϩT 4 -treated rats, two that are obvious for us are the very high levels of serum LH and the less-than-normal levels of T 4 (compared to 3M and 6M rats). Therefore, it appears that adjustments in the doses of LH and T 4 in LHϩT 4 -treated rats would allow us to achieve the desired serum testosterone levels in these aged rats. Luteinizing hormone is produced by the gonadotrophs of the anterior pituitary gland and has a positive correlation with Leydig cell steroidogenic function. Deprivation of endogenous LH causes Leydig cell hypotrophy and reduced steroidogenic capacity [16, 43, 44] , and chronic stimulation of Leydig cells with LH produces Leydig cell hypertrophy and increased steroidogenic capacity [15] . Substantial evidence from studies by Liao and Azhar [45] supports the idea that aging directly affects LH-mediated cholesterol transfer into mitochondria and within the inner mitochondrial membrane. This view is further supported by the observations that significant reductions occur in steroidogenic acute regulatory protein (StAR) [46] and peroxisomes [13] in Leydig cells, which are considered to be crucial factors in cholesterol transport into mitochondria in steroidogenic cells [47, 48] . In addition, enzymes responsible for converting cholesterol to testosterone in Leydig cells are reduced with aging [49] ; these include P450 cholesterol side chain cleavage enzyme, ⌬ 5 -3␤-hydroxysteroid dehydrogenase/⌬ 5 -⌬ 4 -isomerase, 17␣-hydroxylase/C 17-20 lyase, and 17␤-hydroxysteroid [49] . Because substitution of LH to the aged Brown Norway rats has aided tremendously in upgrading the steroidogenic potential of their Leydig cells, testicular aging clearly is closely associated with aging of the pituitary gland.
Thyroid hormones (T 4 and T 3 ) are produced by the follicular cells of the thyroid gland and are regulated by TSH made by the thyrotrophs of the anterior pituitary gland. With aging of the pituitary gland, circulating thyroid hormone levels are reduced [23, 24] . Hypothyroidism arrests differentiation of Leydig cells in the neonatal [20, 21, 45] and adult [19] testis and, more importantly, causes hypotrophy and hypoplasia of Leydig cells in the sexually mature testis [22] . Although direct effects of T 4 on Leydig cells in vivo or in vitro have not been extensively studied, acute treatment of Leydig cells with its metabolite, T 3 , directly enhances Leydig cell steroidogenesis in vitro [50, 51] . Additionally, treatment of mouse Leydig cells with T 3 coordinately augments the levels of StAR protein, StAR mRNA, and steroid production [51] . Because the effects of T 4 in vivo (restricted to the vascular pool) are mediated via T 3 (T 4 is converted to T 3 in target tissues; T 3 is 3-to 5-fold more active than T 4 ) [10] , it is possible to suggest that the stimulatory effects of T 3 in vitro on Leydig cell steroidogenesis [50, 51] reflect the acute effects of thyroid hormone on Leydig cells in vivo as well. Taken together, it is apparent that thyroid hormone is an important factor for Leydig cell steroidogenesis, and that thyroid hormone deficiency during aging could be corrected with exogenous substitution. Manifestation of thyroid hormone deficiency with aging and its effects on testicular steroidogenic function are also in agreement with the concept that aging of the testis is closely associated with pituitary aging.
The observation of Leydig cell hypertrophy in LH-treated rats compares favorably with the results of previous studies on the effects of chronic hCG [52] and LH [16] treatments in sexually mature young rats. However, together with cell hypertrophy, hyperplasia of Leydig cells [16, 52] was also observed in those rats, in contrast to the aged Brown Norway rats of the present study. Whether these differences in response to LH are due to age effects or to strain effects is not clear at present. Whereas LH treatment alone was able to fully restore the average volume of a Leydig cell to those of 3M and 6M rats, it was sufficient only to upgrade the steroidogenic potential of Leydig cells in vitro to that of 12M rats (i.e., above 19M control rat values). Although serum testosterone levels in the aged Brown Norway rats were raised significantly above the 19M control rat value with LH treatment, this increased level was still much less than the serum testosterone levels of 3M and 6M rats. Therefore, it is apparent that exogenous LH substitution alone is not sufficient to rejuvenate the functional aspect of Leydig cells in aged Brown Norway rats toward that of 3M and 6M rats, although a complete recovery in cell size was achieved with LH treatment alone.
Treatment of neonatal rats with T 3 [18, 31] and of adult rats with ethane dimethane sulfonate (which kills Leydig cells within 48 h) [19] causes a stimulation of Leydig cell differentiation from precursor cells. However, to our knowledge, the effects of T 3 or T 4 on the testis interstitium and/ or the Leydig cells in the sexually mature testis in vivo are poorly understood. The present study revealed that, although T 4 treatment alone was partially effective in restoring the average volume of a Leydig cell (i.e., to a level comparable with that of 12M rats), it was equally effective as the LH treatment in upgrading the steroidogenic potential of Leydig cells in vitro to the level of 12M rats. Additionally, T 4 treatment alone was not sufficient to upgrade the serum testosterone levels in 19M rats to those of 3M and 6M rats. Another fact to note is that the dose of T 4 (5 g/day) used in the present study was insufficient to produce circulating T 4 and T 3 levels in the aged rats similar to those in 3M and 6M rats.
With LHϩT 4 treatment, the aged Leydig cells of 19M Brown Norway rats were rejuvenated remarkably; their average cell volume and the steroidogenic potential in vitro were completely reversed, to values similar to those of 3M and 6M rats. Although the serum testosterone levels of these rats were raised only to the level of 12M rats (i.e., 73% recovery compared to 3M rats), this was a 300% increase compared to 19M control rats. Therefore, it is possible to be optimistic regarding the potential of this line of research to achieve the desired serum testosterone levels by adjusting the present LH and T 4 doses (to be lower and higher, respectively). However, even with a 100% success compared to 3M Brown Norway rats, it would still be too early to predict whether this line of treatment could be effective in other strains of rats, other rodents, or other mammalian species in rejuvenation of aged Leydig cells and, thereby, treatment of the androgen deficiency caused by the process of aging.
Currently, androgen deficiencies in aging humans are treated with androgen therapy [11, 12] . The risks of administering androgens to aging men mainly concern the cardiovascular system and the prostate [12] . Cardiovascular effects of androgens are ascribed to the atherogenic effects of androgens on blood-lipid profiles [12] . Apart from these effects, androgens could have other possible deleterious metabolic effects on the cardiovascular system. They induce insulin resistance [53] and increased plasma levels of endothelin, a substance with vasoconstrictor properties produced by the vascular wall [54] . Regarding the effects of androgens on the prostate, benign prostatic hyperplasia and prostate cancer are the main concerns [12] . Therefore, if the present findings are, in fact, applicable to humans, a potential exists to develop an alternative to androgen therapy for minimizing the effects of androgen deficiency during age advancement. Clearly, additional research is required to evaluate the feasibility of this approach.
